ACT — AlzChem AG Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMid CapHigh Flyer

Annual income statement for AlzChem AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	379	422	542	541	554
Cost of Revenue
Gross Profit	242	259	272	308	361
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	349	385	506	485	475
Operating Profit	30.7	37.6	35.9	55.5	79
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	27.2	36.5	41.3	48.2	75.3
Provision for Income Taxes
Net Income After Taxes	19.9	27.8	30.2	34.8	54.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	19.7	27.6	30.1	34.6	54.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19.7	27.6	30.1	34.6	54.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.94	2.72	2.96	3.4	5.31
Dividends per Share